Canaan Partners IX’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$66.6M Hold
4,244,381
100% 1
2016
Q2
$43.4M Sell
4,244,381
-640,374
-13% -$6.54M 100% 1
2016
Q1
$63M Hold
4,884,755
100% 1
2015
Q4
$102M Buy
+4,884,755
New +$102M 100% 1